Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SkyePharma PLC (OTC Pink - Current Information:SKYEY)

4.92
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
3.85
Today|||52-Week Range
5.97
-3.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues88.9M79.5M98.0M121.5M
 
 
 
 
 
Cost of Goods Sold31.9M29.6M46.7M49.9M
 
 
 
 
 
Depreciation And Amortization4.3M4.8M6.7M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income52.6M45.1M44.6M66.0M
 
 
 
 
 
General Expenses33.5M26.1M24.0M29.0M
 
 
 
 
 
Research And Development27.0M20.5M16.9M19.9M
 
 
 
 
 
Total Operating Expenses69.7M60.5M77.4M84.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income19.2M19.0M20.7M37.0M
 
 
 
 
 
Extraordinary Credit644.0K8.0M--658.6K
 
 
 
 
Extraordinary Charge-3.4M-26.4M-156.6K-43.8M
 
 
 
 
 
Interest Expense On Debt19.0M18.8M22.1M11.5M
 
 
 
 
 
Other Expenses644.0K1.8M-156.6K1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-16.6M-1.6M-16.3M
 
 
 
 
 
Income Taxes-966.0K-318.6K-2.8M-987.9K
 
 
 
 
 
Discontinued Operations0.009.9M0.000.00
 
 
Net Income-2.6M-7.0M1.3M-17.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.0M33.2M51.9M85.3M
 
 
 
 
 
Shares To Calculate EPS Diluted27.0M33.2M53.7M85.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.10-$0.21$0.03-$0.20
 
 
 
 
 
EPS Diluted-$0.10-$0.21$0.02-$0.20